
KALA BIO
Development and commercialization of therapeutics using our proprietary nanoparticle-based Mucus Penetrating Particles.
Market cap
$29.0m
Enterprise value
$19m
Share price
$4.76 KALA
Authorizing premium user...
Development and commercialization of therapeutics using our proprietary nanoparticle-based Mucus Penetrating Particles.